Search research articles
Contact Us
Filters
Showing results (21-30 of 238) with videos related to
Page
of 24
Sort By:
Seminars in Respiratory and Critical Care Medicine
|
July 30, 2005
Factors predicting response to EGFR tyrosine kinase inhibitors
Jeffrey A Engelman, Pasi A Jänne
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
Jeffrey A Engelman, Pasi A Jänne
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2013
ALK in lung cancer: past, present, and future
Alice T Shaw, Jeffrey A Engelman
Cell
|
December 20, 1991
HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer
A Engelman, K Mizuuchi, R Craigie
Cancer Prevention Research (Philadelphia, Pa.)
|
September 3, 2010
Chemoprevention meets glucose control
Jeffrey A Engelman, Lewis C Cantley
Cancer Cell
|
May 6, 2008
A sweet new role for EGFR in cancer
Jeffrey A Engelman, Lewis C Cantley
Science Signaling
|
September 26, 2013
Bypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancer
Matthew J Niederst, Jeffrey A Engelman
Cancer Cell
|
March 22, 2014
ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics
Carlos L Arteaga, Jeffrey A Engelman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2006
The role of the ErbB family members in non-small cell lung cancers sensitive to epidermal growth factor receptor kinase inhibitors
Jeffrey A Engelman, Lewis C Cantley
The Journal of Biological Chemistry
|
June 8, 1999
Multiple integrase functions are required to form the native structure of the human immunodeficiency virus type I intasome
H Chen, S Q Wei, A Engelman
Page
of 24
Search research articles
Search
Showing results (21-30 of 238) with videos related to
Sort By:
Page
of 24
Seminars in Respiratory and Critical Care Medicine
|
July 30, 2005
Factors predicting response to EGFR tyrosine kinase inhibitors
Jeffrey A Engelman, Pasi A Jänne
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
Jeffrey A Engelman, Pasi A Jänne
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2013
ALK in lung cancer: past, present, and future
Alice T Shaw, Jeffrey A Engelman
Cell
|
December 20, 1991
HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer
A Engelman, K Mizuuchi, R Craigie
Cancer Prevention Research (Philadelphia, Pa.)
|
September 3, 2010
Chemoprevention meets glucose control
Jeffrey A Engelman, Lewis C Cantley
Cancer Cell
|
May 6, 2008
A sweet new role for EGFR in cancer
Jeffrey A Engelman, Lewis C Cantley
Science Signaling
|
September 26, 2013
Bypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancer
Matthew J Niederst, Jeffrey A Engelman
Cancer Cell
|
March 22, 2014
ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics
Carlos L Arteaga, Jeffrey A Engelman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2006
The role of the ErbB family members in non-small cell lung cancers sensitive to epidermal growth factor receptor kinase inhibitors
Jeffrey A Engelman, Lewis C Cantley
The Journal of Biological Chemistry
|
June 8, 1999
Multiple integrase functions are required to form the native structure of the human immunodeficiency virus type I intasome
H Chen, S Q Wei, A Engelman
Page
of 24